Risk factors

Haemonetics (HAE) risk factors

Item 1A of every Haemonetics Corp. 10-K on file, and what changed from one year to the next.

Open HAE in Gloomberb →
  • FY2026 10-K risk factors

    37 risks, 1 new, 10 reworded since the prior year. A new global ERP rollout could disrupt orders, shipments, customer support, invoicing, payments, and contractual performance.

    Filed May 20, 2026
  • FY2025 10-K risk factors

    36 risks. Haemonetics operates across Plasma, Blood Center, and Hospital segments, facing heavy customer concentration and strict FDA regulations. Growth relies on ongoing product innovation, acquisitions like OpSens and Attune Medical, and continuous supply chain execution. Substantial debt, convertible notes, and international operations expose the company to currency, geopolitical, and tax volatility.

    Filed May 21, 2025